National review of deaths among HIV-infected adults

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 8, Issue 3, 2008, Pages 250-252

  Lucas, S B ^a   Curtis, H ^b,d   Johnson, Ma ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b British HIV Association   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

HIV diagnosis; HIV infection; Mortality

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC LIVER DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS; LIVER FAILURE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PATIENT CARE; REVIEW; VIRUS LOAD;

EID: 46949096645     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.8-3-250     Document Type: Review

References (16)

1. Mocroft A, Brettle R, Kirk O et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS 2002;16:1663-71.
2. Crum NF, Riffenburgh RH, Wegner S et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006;41:194-200.
3. Palella FJ, Baker RK, Moorman AC et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34.
4. Chadborn TR, Delpech VC, Sabin CA et al. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). AIDS 2006;20:2371-9.
5. Sullivan AK, Curtis H, Sabin CA, Johnson MA. Newly diagnosed HIV infections: review in UK and Ireland. BMJ 2005;330:1301-2.
6. Miller RF, Allen E, Copas A, Singer M, Edwards SG. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax 2006;61:716-21.
7. Gazzard B. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med 2006;7:487-503.
8. Lewden C, Bonnet F, Bevilacqua S et al. Causes of death in HIV-infected French drug users, 1995-2000. Ann Med Interne (Paris) 2002; 153(7 Suppl):2S4-10.
9. Rosenthal E, Pialoux G, Bernard N et al. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat 2007;14:183-8.
10. Data Collection on Adverse Events of Anti-HIV Drugs Study Group (D:A:DStudy). Liver-related deaths in persons infected with the human immunodeficiency virus. Arch Intern Med 2006;166:1632-41.
11. Kirk GD, Merlo C, O'Driscoll P et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 2007;45:103-10.
12. D'Arminio Monforte A, Abrams D, Pradier C et al. HIV-induced immunodeficiency and risk of fatal AIDS-defining and non-AIDS-defining malignancies: results from the D:A:D study. Abstract presented at the 14th Conference on Retroviruses and Opportunistic Infections, 25-28 February 2007, Los Angeles USA (Abstract 84).
13. Grulich AE, Li Y, McDonald A et al. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002;16:1155-61.
14. Phillips A, Leen C, Wilson A, Sabin C. Trends over calendar time in the prevalence of patients with extensive triple class virological failure in the UK. Abstract presented at the 13th annual conference of the British HIV Association with the British Infection Society, 25-28 April 2007, Edinburgh, UK (abstract O1). HIV Medicine 2007;8(Suppl 1):1.
15. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55;1-17.
16. World Health Organization. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: WHO, 2007.